Westcape Biotech (Pty) Ltd, in Stellenbosch in South Africa, was established in 2012. Westcape Biotech was originally a joint venture with the innovative Expressive Research, a commercial biotechnology business offering quality tissue culture, diagnostics and molecular research services mainly to the agricultural sector in South Africa and beyond.
On 28 May 2018, Enza Zaden Beheer B.V. purchased the remaining shares in Westcape Holdings (Pty) Ltd. from venture partner Expressive Research B.V. This means that Enza Zaden is now the sole owner of Westcape Holdings (Pty) Ltd. and the subsidiary Westcape Biotech (Pty) Ltd (hereafter referred to as Westcape).
Westcape previously performed various biotechnological services for Enza Zaden and external clients. Consequent to this change in shareholding, Westcape has become a full research and development station of Enza Zaden for specific support activities in breeding and no longer performs services for external clients.
The decision was made to integrate the three separate Enza Zaden entities operating in South Africa into one company. The company entities of Enza Zaden South Africa Seed Operations and Enza Zaden South Africa Commercial (Pty) Ltd. will cease to exist and, together with Westcape Biotech (Pty) Ltd, will operate under the name Enza Zaden South Africa (Pty) Ltd.